Is the risk of morbidity and rare mortality worth the cure?
Cancer
; 41(1): 377-80, 1978 Jan.
Article
in En
| MEDLINE
| ID: mdl-626942
ABSTRACT
Many more children with cancer are being cured, often as a result of aggressive treatment regimens. These employ several modalities and multiple chemotherapeutic agents. The acute complications resulting from this type of treatment are relatively well known. Those that develop later are becoming better understood; some are formidable. The challenge in pediatric oncology lies in developing better treatment strategies with a view to minimizing normal tissue damage while achieving higher cure rates. The cooperative clinical trial mechanism is well-suited to testing new treatment regimens designed to achieve these goals.
Search on Google
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Iatrogenic Disease
/
Neoplasms
Type of study:
Etiology_studies
/
Risk_factors_studies
Limits:
Child
/
Humans
Language:
En
Journal:
Cancer
Year:
1978
Document type:
Article